Sunresin’s International Symposium on Peptide and Oligonucleotide Technologies Concludes Successfully at Its Global Headquarters in Xi’an
December 3–4, Xi’an, China — Hosted at Sunresin’s global headquarters in Xi’an, the International Symposium on Peptide and Oligonucleotide Technologies: Innovation and Application Frontiers concluded successfully this week. The two-day event brought together more than 400 participants from around the world, marking one of the most influential industry gatherings in the field of peptide and nucleic acid synthesis technologies.
Through a rich program of keynote speeches, technical workshops, interactive discussions, and product exhibitions, the symposium created a global platform for global exchange while showcasing Sunresin’s leadership in solid-phase synthesis carriers for peptides and oligonucleotides. The event injected strong momentum into the high-quality development of biopharmaceutical materials.

A Global Gathering of Expertise and Innovation
The symposium welcomed experts from pharmaceutical companies, CDMOs, universities, and research institutions worldwide. Participants shared forward-looking insights into peptide and oligonucleotide synthesis technologies, industrial applications, and next-generation innovation pathways.

International Thought Leaders Set the Direction
Prof. Fernando Albericio from the University of KwaZulu-Natal delivered an in-depth analysis of the scientific foundations of solid-phase synthesis and emerging trends in oligonucleotide therapeutics. His perspective on green synthesis technologies resonated strongly with attendees and opened new possibilities for sustainable drug manufacturing.

Domestic Experts Offer Practical Perspectives
Chinese scholars including Prof. Su Xianbin and Dr. Yan Wuming presented solutions grounded in real-world industrial practice. Their insights ranged from transitioning “green synthesis to sustainable manufacturing” to enzymatic fragment ligation for siRNA, providing actionable guidance for process optimization and scale-up.
Industry Leaders Share Application Experience
Experts from Roche, CordenPharma, Polypeptide, and other globally recognized pharmaceutical companies offered user-centric evaluations of solid-phase synthesis carriers. Their discussions on developing efficient, sustainable continuous liquid-phase processes highlighted the decisive role of high-quality synthesis carriers in modern drug manufacturing.

Sunresin Showcases Latest Technological Breakthroughs
Sunresin’s peptide resin R&D team, oligonucleotide carrier development team, and application engineers unveiled several major innovations, including:
- New-generation solid-phase synthesis resins for peptide manufacturing
- High-loading SPOS materials designed for oligonucleotide purification
- Sunresin’s integrated “synthesis + purification” solution for nucleic acid drug development
These advancements underscored Sunresin’s comprehensive strength across material design, process engineering, and application support.
Technology, Industry, and Market Trends Converge
Peptide and oligonucleotide therapeutics—known for high specificity, strong efficacy, and favorable safety profiles—have become central pillars in treating metabolic diseases, oncology, rare diseases, and neurodegenerative disorders.
Global market data reflects this rapid rise:
- The GLP-1 therapeutics market is expected to reach USD 60 billion by 2025, and may exceed USD 110 billion by 2030.
- The oligonucleotide drug sector is undergoing explosive growth, with multiple approved products and active pipelines targeting diseases such as hepatitis B and Huntington’s disease.
- In China, more than 100 peptide-focused enterprises have emerged, driving strong demand for high-performance, green, and scalable synthesis carriers.
Amid these trends, Sunresin draws on more than 20 years of expertise in adsorption and separation technologies to provide high-stability, green-compatible, and industrial-scale synthesis carriers. From laboratory research to full commercial production, and from domestic deployment to global collaboration, Sunresin continues to address key industry challenges and earn the trust of leading pharmaceutical manufacturers worldwide.

A Milestone Event for Sunresin and the Global Biopharma Community
The successful conclusion of the symposium demonstrates Sunresin’s long-standing commitment to advancing global collaboration, technological innovation, and industrial progress in peptide and nucleic acid materials.
By connecting scientific breakthroughs with practical applications, Sunresin is helping accelerate the development and commercialization of next-generation biopharmaceuticals.
Sunresin will continue to drive innovation, deepen global partnerships, and contribute to the future of high-end biopharmaceutical materials.
Free Quote
Resources
Adsorbent Resin
Bio-Pharmaceutical & Life Science
Enzyme Carriers
Hydrometallurgy & Mining
Chelating Resin
Chemical Industry
Chromatographic Media
Wastewater Treatment&Reuse
Food & Beverage Industries
Ion Exchange Resin
Civil & Industry Water Treatment
Equipments And Projects
Plant Extraction
Catalyst Resin
Solid Phase Peptide Synthesis
Product
Application
Contact Us
Sunresin Park,No.135, jinye Road, Xi’an Hi-tech Industrial Development Zone, Shaanxi-710076, China
seplite@sunresin.com
seplite_europe@sunresin.com
+86-29-89182091
Our Product List
Latest News
19
2025 11
Leave a Message
Please send any questions you want to know, we will reply to you immediately.
Choose File
Submit